Comparative statistics by cancer site (ICD-10)

ICD-10: Comparative statistics by registry

Table 2a: Number and proportion of cases with complete/incomplete follow-up and median follow-up (in months) by site


Click on country-registry for comparison

Flag Country Registry Registration periodNo. of cases included Complete FUIncomplete FU: loss to FU% with Complete FU at 5 yearsMedian FU (in months)
Alive/deadAt end of FUNo.%% lost to FU: years from diagnosis
No.%<11-33-5>5
China - Shangai1992-19952988298099.780.30.10.10.10.099.86.8
India - Barshi1993-2000979699.011.00.00.00.01.0100.03.9
India - Chennai1990-19992016181890.21989.86.70.90.41.892.06.9
India - Karunagappally1991-199710610599.110.90.90.00.00.099.16.5
India - Mumbai1992-19943128275988.236911.87.50.40.23.791.95.0
Thailand - Chiang Mai1993-1997887787.51112.58.02.31.11.188.62.7
Thailand - Lampang1990-2000113113100.000.00.00.00.00.0100.09.6
Thailand - Songkhla1990-199932125980.76219.312.84.01.60.981.67.1
Uganda - Kampala1993-199718015284.42815.612.82.80.00.084.47.2
Zimbabwe - Harare1993-1997131131100.000.00.00.00.00.0100.02.3



Other tables available:

- Table 1: Data quality indices - Proportion (%) of histologically verified and death certificate only cases, number and proportion of included and excluded cases by site
- Table 2a: Number and proportion of cases with complete/incomplete follow-up and median follow-up (in months) by site
- Table 2b: Number and proportion of cases by vital status and median follow-up (in months) by site
- Table 3: Comparison of 1-, 3- and 5-year absolute and relative survival and 5-year age-standardized relative survival (ASRS) by site
- Table 4: Site-wise number of cases, 5-year absolute and relative survival by sex and relative survival by age group
- Table 5b: Proportion (%) of cases and 5-year absolute survival by extent of disease and site
- Table 6: Comparison of 5-year absolute and relative survival of cases diagnosed
- Table 7b: Up-to-date 5-year relative survival estimates using cohort and period approaches by site and calendar period
- Table 8: Up-to-date 5-year relative survival estimates using cohort and period approaches by site and calendar period
- Table 9: Up-to-date 10- and 15-year relative survival estimates using cohort and period approaches by site and calendar period